コンテンツへスキップ
Merck

880230P

Avanti

18:1 PEG5000 PE

Avanti Research - A Croda Brand

別名:

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt)

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

CAS番号:
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


製品名

18:1 PEG5000 PE, Avanti Research - A Croda Brand 880230P, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 2 × 100 mg (880230P-200mg), pkg of 1 × 25 mg (880230P-25mg)

manufacturer/tradename

Avanti Research - A Croda Brand 880230P

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@@](COP([O-])(OCCNC([(OCH2CH2)113OCH3])=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+]

Application

18:1 PEG5000 PE or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000 may be used in lipid bilayer preparation, and DOX free base loaded mixed dendrimer micelles (MDM DOX) preparation for tumor targeted delivery of siRNA and drugs.

Biochem/physiol Actions

18:1 PEG5000 PE, also referred as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (PEG5k-DOPE) in combination with lipid modified dendrimer copolymer supports co-delivery of siRNA and drugs to tumors.

Packaging

5 mL Clear Glass Sealed Ampule (880230P-25mg)
5 mL Clear Glass Sealed Ampule (880230P-200mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


Still not finding the right product?

Explore all of our products under


保管分類

11 - Combustible Solids

wgk

WGK 3

flash_point_f

No data available

flash_point_c

No data available



最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 資料 section.

サポートが必要な場合は、お問い合わせください カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする



TCR--pMHC bond conformation controls TCR ligand discrimination
Sasmal DK, et al.
Cellular & Molecular Immunology (2019)
Jiayi Pan et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 136, 18-28 (2019-01-12)
Multidrug resistance (MDR) significantly decreases the therapeutic efficiency of anti-cancer drugs. Its reversal could serve as a potential method to restore the chemotherapeutic efficiency. Downregulation of MDR-related proteins with a small interfering RNA (siRNA) is a promising way to reverse
Dibyendu K Sasmal et al.
Cellular & molecular immunology, 17(3), 203-217 (2019-09-19)
A major unanswered question is how a TCR discriminates between foreign and self-peptides presented on the APC surface. Here, we used in situ fluorescence resonance energy transfer (FRET) to measure the distances of single TCR-pMHC bonds and the conformations of